Trials / Terminated
TerminatedNCT01676090
IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
An Epidemiologic, Descriptive and Cross-sectional Study of the IGF-1, IGFBP-3 and ALS Normative Ranges in a Healthy Paediatric Spanish Population, Divided Into Chronological Age, Sex and Pubertal Stage
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 304 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To determine the normative ranges of the Insulin-like Growth Factor 1 (IGF-1), Insulin-like growth factor-binding protein 3 (IGFBP-3), Acid-Labile Subunit (ALS) according to age, sex and pubertal stage of a healthy paediatric Spanish population.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-08-30
- Last updated
- 2019-01-11
Locations
9 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01676090. Inclusion in this directory is not an endorsement.